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detection efficiency of the detector response was also 
included. A relation between the variance and the absorbed 
dose was derived for the two spectra (Low energy (LE): 60 
kV/Al; High energy (HE): 120 kV/Al/Cu/Ag). The material 
decomposition method proposed in [2] was used. A 360º CBCT 
irradiation (600 frames, 10 ms/frame) with 8 different mAs 
values from 30 to 720 mAs was designed. For each tube 
voltage and irradiation setup, the variance in the measured 
attenuation coefficient at the center of the phantom was 
determined analytically. The uncertainty on the estimated 
effective atomic number Z was evaluated using an error 
propagation model expressed in terms of derivatives of the 
LE and HE images (finite differences) and the variances of LE 
and HE images (analytical expression). In order to estimate a 
ratio between LE and HE doses (D1 and D2) that minimizes 
the error in the effective Z, the proportion of D1 with respect 
to D2 was varied from 5% to 95% while keeping the phantom 
dose at the center to a constant value of 20 mGy. 
Results: Error in the effective Z presents a minimum when 
the percentage of D1 and D2 with respect to the total 
imaging dose is 40% and 60%, respectively, which corresponds 
to 120 mA and 80 mA at fixed exposure times. The high 
energy spectrum is more penetrating than the low energy 
spectrum when traversing the phantom. However, this effect 
is compensated with the lower attenuation coefficient and 
the poorer efficiency of the detector response at high 
energy. 
Conclusions: From these preliminary results, we conclude 
that similar doses between the two voltages should be used 
to optimize the material decomposition of a homogeneous 
phantom with dual-energy imaging. If an imaging protocol to 
minimize the dose to the patient is contemplated, the 
proposed method is a useful tool to determine the exposure 
that minimizes potential errors in the effective Z. The 
validity of this method is currently being confirmed using 
Monte Carlo simulations. 
[1] J.C.Gore and P.S.Tofts. Phys Med Biol, 23, 1176-1182 
(1978). 
[2] M. Bazalova , J.F. Carrier, L. Beaulieu and F. Verhaegen. 
Phys Med Biol, 53, 2439-2456 (2008).  
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Purpose/Objective: Moving towards higher and more 
conformal doses, precise patient positioning is crucial. The 
gold standard for patient positioning is the use of daily CBCT. 
To uphold a high and consistent standard for image 
registration, offline reviews of the online performed image 
registrations are needed. This is a time-consuming task, 
lacking appropriate tools to quantify the 'correctness' of a 
registration, and to aid the clinical decision making. We 
describe here a deformable registration (DR) tool which 
automatically quantifies the quality of an image registration 
in order to flag suspect images for manual review. 
Materials and Methods: Using DR of the daily CBCT against 
the reference planning CT, we calculate the resulting 
transformation vector field to quantify the difference 
between the two scans. From this we extract positional data 
for all delineated structures, and determine where and by 
how much the displacement exceeds tolerance. This allows 
us monitor trends in positioning of individual patients, 
selecting them for manual review and intervention, as well as 
monitoring the general quality of image registrations in the 
clinic. 
Results: 
 
 
At present we have tested the method on 15 head & neck 
cancer patients. We can extract the relevant information 
from the DR, showing where and how much the CBCT image 
deviates from the planning CT. The figure shows an example 
of the extracted information. For 3 different patients we 
show the volume of the part of the high-dose CTV (full lines) 
and spinal cord (dashed lines) which at the given fraction is 
5mm or more outside the delineated area in the planning CT. 
The first (blue) is well positioned during all sampled 
fractions, the second (red) also starts out well, but on 
fractions 19 and 30 there are significant deviations on the 
spinal cord due to flexing of the neck (the deviation on the 
CTV in fraction 30 is due to tumor shrinkage). The third 
(green) is from a patient safety incident where a patient was 
positioned outside tolerance for part of the treatment, the 
error not being discovered until the second offline review, 
but here the mistake is immediately visible, and when the 
error is finally corrected the figure shows the patient being 
well positioned for the remainder of the treatment. 
Conclusions: We are developing a method for automatically 
reviewing CBCT images as an additional help for the 
online/offline review of daily images. Our first results are 
very promising, but soft tissue registration still requires some 
work to be robust for special cases such as large tumors. 
Besides evaluating individual CBCTs, this method will also 
allow us to follow and trend individual patients as well as 
monitoring the general quality of patient positioning in our 
clinic over time. Currently we are implementing a dose 
distribution analysis, letting us prioritize high dose areas 
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when evaluating mismatches. We are also preparing to 
further test the method in the daily clinic in parallel with our 
current image review routines for a comparative study.  
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Purpose/Objective: The increased use of image-guided 
radiotherapy (IGRT) has enabled dose-response modelling 
using motion-inclusive (rather than planned) dose 
distributions. Robust motion-inclusive dose-response 
parameters would require both large cohorts and daily 
imaging (e.g. cone-beam CT, CBCT), which could lead to 
substantial clinical work-load including image registration, 
dose-recalculation and dose accumulation. Systematic 
changes in body dimensions (e.g. due to weight loss) during 
the course of RT could potentially assist to determine the 
need for dose-recalculation. The aim of this study was to 
investigate the need for dose-recalculation in a cohort of 
prostate cancer patients treated with IGRT.  
Materials and Methods: From 41 patients treated with IGRT 
for prostate cancer in 2013, five patients were selected 
based on their large treatment-course variations in source-
skin distance (SSD, measured at the anterior, left and right 
side). To isolate the effect of body dimension changes, dose 
re-calculations without heterogeneity corrections were 
performed on the pre-RT CT and on the CBCTs acquired 
during the first phase of RT. The resulting dose distributions 
were compared using the generalised equivalent uniform 
dose (gEUD) for the rectum (a=11) and bladder (a=8), as well 
as the maximum point doses in these organs and in the body. 
Finally, changes in dose metrics between the pre-RT CT and 
the re-calculated dose distributions on the CBCTs were 
correlated (Pearson’s correlation coefficient, Pr) with 
changes in body dimensions. Changes in SSD were quantified 
as the cross-sectional area (CSA) measuring changes in the 
isocenter body contour area (with a rectangular 
approximation), and as the contour surface change (CVC) 
adding surface changes in contour slices close to the 
maximum dose point. 
Results: Overall, dose differences were within 1% (Table 1) 
but differences exceeding 5% were seen for single scans of 
which the majority resulted from a single patient (Figure 1 
(left)). The correlation between CSA and all five dose metrics 
was typically modest with the strongest correlation found 
with the rectum and bladder gEUDs (Pr= -0.63, -0.51, Figure 1 
(right)). The CVC was slightly weaker correlated with the 
rectum gEUD but overall the correlations with the other dose 
metrics remained modest (Table 1). 
 
 
 
Conclusions: Variations in body dimensions during RT for 
prostate cancer were found to cause differences in dose 
distributions typically within 1% although larger individual 
differences (>5%) were seen. Treatment course SSD variations 
can be used as an indicator of the need for CBCT-based re-
calculations to take variations in body dimension into 
account.  
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Purpose/Objective: The use of 18F-fluorodeoxyglucose 
positron emission tomography (FDG-PET) in the delineation 
process in Radiation Oncology is constantly growing. The 
accuracy in metabolic volume sizing is nowadays very 
important in relation to the high conformity of dose 
distributions achievable with modern equipment. 
In this work we propose a new method of automatic tumor 
segmentation based on a Dirichlet process (DP) mixture 
model applied to the distribution of the voxel activity 
concentration in PET-CT images. 
Materials and Methods: We tested the method on a IEC 
phantom acquired by a Philips Gemini Big Bore TF scanner, 
on a digital phantom simulating spherical/uniform lesions and 
tumours (irregular in shape and activity), and on a 
consecutive series of patients. The IEC body phantom 
consisted of 6 spherical inserts with diameters in the range 
10-37 mm. Each sphere was filled with 18FDG using 9 different 
target-to-background ratios (2.5 to 70). The scan time per 
bed was 5 min. The digital phantom simulates 3 spheres with 
uniform activity (volumes of 5, 13 and 37 ml) and 3 irregular 
structures (volumes of 45, 62 and 133 ml). The clinical cases 
were 10 lung cancer and 10 oesophageal cancer patients (2.5 
MBq/kg). We applied an automatic, statistically-based 
